Sanna Uskela et al., at North Karelia Central Hospital-Heart Center, Finland, conducted a retrospective single-center registry study that focused on the use of drug-coated balloon (DCB)-only strategy for treating de novo left main coronary artery disease.
Straumann Group 2023 full-year results webcast – Biotech Investments
Straumann Holding AG / Key word(s): Annual Results/Miscellaneous Invitation: Straumann Group 2023 full-year results webcast 15.02.2024 / 13:26 CET/CEST Date: Tuesday, February 27th, 2024 Time: